{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:18:12Z","timestamp":1759580292884},"reference-count":70,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":294,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2001,3]]},"abstract":"<jats:p>p16 gene deletions are present in about 70% of\u00a0primary paediatric T\u2010cell acute lymphoblastic leukaemia (T\u2010ALL) and 20% of common\/precursor B\u2010cell ALL cases. It is not clear what the impact of the frequent p16 deletions is within the subgroup of T\u2010lineage ALL. We studied the relationship between p16\/p19<jats:sup>ARF<\/jats:sup> deletions, using fluorescence <jats:italic>in situ<\/jats:italic> hybridization, and <jats:italic>in vitro<\/jats:italic> drug resistance and prognosis in childhood T\u2010ALL at diagnosis. The cellular drug resistance was measured with the methyl thiazol tetrazoliumbromide assay using a panel of drugs and the thymidylate synthase inhibition assay for methotrexate. There was a complete overlap of individual LC<jats:sub>50<\/jats:sub> values of p16 gene homozygously deleted and p16 germ\u2010line cases for most of the nine classes of drugs tested. The only difference was for dexamethasone: the p16\u2010deleted group was more sensitive than the germ\u2010line p16 group (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7030). The homozygously deleted p16 T\u2010ALL patients (<jats:italic>n<\/jats:italic>\u2003=\u200334) treated with the modern multiagent chemotherapy schemes of the Dutch Childhood Leukaemia Study Group ALL\u2010VII\/\u2010VIII or Co\u2010operative ALL\u201092\/\u201097 protocols have a significantly lower 5\u2010year disease\u2010free survival (DFS) than germ\u2010line p16 T\u2010ALL (<jats:italic>n<\/jats:italic>\u2003=\u200325) (65\u00b71\u2003\u00b1\u20039\u00b71% vs. 95\u00b75\u2003\u00b1\u20034\u00b74%, <jats:italic>P<\/jats:italic><jats:sub>log rank<\/jats:sub>= 0\u00b7021). Hence, this study identifies a subpopulation of primary childhood T\u2010ALL that appears to have an extremely high DFS. However, the observed differences in outcome do not seem to be related to intrinsic resistance for the tested drugs.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2001.02586.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:31:41Z","timestamp":1047364301000},"page":"680-690","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["<i>In vitro<\/i> drug resistance and prognostic impact of p16<sup>INK4A<\/sup>\/P15<sup>INK4B<\/sup> deletions in childhood T\u2010cell acute lymphoblastic leukaemia"],"prefix":"10.1111","volume":"112","author":[{"given":"N. L.","family":"Ramakers\u2010van Woerden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. M.","family":"Slater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. H.","family":"Loonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. B.","family":"Beverloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Van Drunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Heyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Calero Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"Rots","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. R.","family":"Van Wering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. A.","family":"Kamps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. E.","family":"Janka\u2010Schaub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J. P.","family":"Veerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1159\/000132972"},{"key":"e_1_2_6_3_1","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1182\/blood.V88.8.3083.bloodjournal8883083","article-title":"Frequent deletion in the methylthioadenosine phosphorylase gene in T\u2010cell acute lymphoblastic leukemia \u2013 strategies for enzyme\u2010targeted therapy","volume":"88","author":"Batova A.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(93)90604-U"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1996.tb00463.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/362849a0"},{"key":"e_1_2_6_7_1","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood.V72.6.1891.1891","article-title":"Clinical features and outcome in childhood T\u2010cell leukemia\u2010lymphoma according to stage of thymocyte differentiation: a Pediatric Oncology Group Study","volume":"72","author":"Crist W.M.","year":"1988","journal-title":"Blood"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001113220202"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.9.3105.3105"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0145-2126(97)00007-6"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870615)59:12<2020::AID-CNCR2820591209>3.0.CO;2-I"},{"key":"e_1_2_6_12_1","first-page":"21","article-title":"A new type of p16INK4\/MTS1 gene transcript expressed in B\u2010cell malignancies","volume":"11","author":"Duro D.","year":"1995","journal-title":"Oncogene"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199309086995"},{"key":"e_1_2_6_14_1","first-page":"7781","article-title":"Deletion of alpha\u2010, beta\u2010, and omega\u2010interferon genes in malignant cells from children with acute lymphocytic leukemia","volume":"50","author":"Einhorn S.","year":"1990","journal-title":"Cancer Research"},{"key":"e_1_2_6_15_1","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood.V85.10.2685.bloodjournal85102685","article-title":"Detection of homozygous deletions of the cyclin\u2010dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features","volume":"85","author":"Fizzotti M.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_16_1","first-page":"739","article-title":"Comparison of outcome, clinical, laboratory, and immunological features in 164 children and adults with T\u2010ALL. The Groupe d'Etude Immunologique des Leucemies","volume":"4","author":"Garand R.","year":"1990","journal-title":"Leukemia"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.3.1016"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)92596-2"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1182\/blood.V84.12.4038.bloodjournal84124038","article-title":"Candidate tumor\u2010suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T\u2010 but not from B\u2010cell lineage acute lymphoblastic leukemias","volume":"84","author":"Hebert J.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.5.1512"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.1.22"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.8.2959"},{"key":"e_1_2_6_23_1","first-page":"501","article-title":"Alteration of CDKN2\/p16 in human astrocytic tumors is related with increased susceptibility to antimetabolite anticancer agents","volume":"17","author":"Iwadate Y.","year":"2000","journal-title":"International Journal of Oncology"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004310050459"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1043794"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8153634"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.14.8292"},{"key":"e_1_2_6_28_1","first-page":"1226","article-title":"Intensive treatment of children with acute lymphoblastic leukemia according to ALL\u2010BFM\u201086 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL\u20107 (1988\u201391)","volume":"94","author":"Kamps W.A.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1991.333"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.446"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.3.751.bloodjournal853751"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.7.2723"},{"key":"e_1_2_6_33_1","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1182\/blood.V89.11.4161","article-title":"Homozygous deletion of the p16\/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome","volume":"89","author":"Kees U.R.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.11.4243"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3479843"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.4.1092.1092"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/362847a0"},{"key":"e_1_2_6_38_1","first-page":"2995","article-title":"A novel p16INK4A transcript","volume":"55","author":"Mao L.","year":"1995","journal-title":"Cancer Research"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.3.1158"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3835(97)04714-9"},{"key":"e_1_2_6_41_1","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1182\/blood.V74.5.1801.1801","article-title":"An additional breakpoint region in the BCL\u20101 locus associated with the t(11;14)(q13;q32) translocation of B\u2010lymphocytic malignancy","volume":"74","author":"Meeker T.C.","year":"1989","journal-title":"Blood"},{"key":"e_1_2_6_42_1","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood.V86.4.1269.bloodjournal8641269","article-title":"Homozygous deletions of p16\/MTS1 gene are frequent but mutations are infrequent in childhood T\u2010cell acute lymphoblastic leukemia","volume":"86","author":"Ohnishi H.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_43_1","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1182\/blood.V85.9.2321.bloodjournal8592321","article-title":"Frequent deletion of p16INK4a\/MTS1 and p15INK4b\/MTS2 in pediatric acute lymphoblastic leukemia","volume":"85","author":"Okuda T.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0888-7543(05)80238-1"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(88)90294-7"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91029-T"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401129"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-3955(05)70532-0"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90214-7"},{"key":"e_1_2_6_50_1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.V85.3.657.bloodjournal853657","article-title":"p16 gene homozygous deletions in acute lymphoblastic leukemia","volume":"85","author":"Quesnel B.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(77)90052-3"},{"key":"e_1_2_6_52_1","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood.V93.3.1067","article-title":"Differential methotrexate resistance in childhood T\u2010 versus common\/preB\u2010 acute lymphoblastic leukemia can be measured by an in situ thymidylate synthase inhibition assay, but not by the MTT assay","volume":"93","author":"Rots M.G.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.5.1677"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400779"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(94)00266-e"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.13.20.2670"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.4.740"},{"key":"e_1_2_6_58_1","first-page":"2730","article-title":"Philadelphia chromosome\u2010positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome","volume":"92","author":"Schrappe M.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/366704a0"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.18.1.378"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V75.1.166.166"},{"key":"e_1_2_6_62_1","first-page":"2988","article-title":"Complex structure and regulation of the p16 (MTS1) locus","volume":"55","author":"Stone S.","year":"1995","journal-title":"Cancer Research"},{"key":"e_1_2_6_63_1","first-page":"3199","article-title":"Reversible, p16\u2010mediated cell cycle arrest as protection from chemotherapy","volume":"56","author":"Stone S.","year":"1996","journal-title":"Cancer Research"},{"key":"e_1_2_6_64_1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood.V86.2.755.bloodjournal862755","article-title":"Analysis of a family of cyclin\u2010dependent kinase inhibitors: p15\/MTS2\/INK4B, p16\/MTS1\/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood","volume":"86","author":"Takeuchi S.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.12.6937"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.6.2214"},{"key":"e_1_2_6_67_1","first-page":"735","article-title":"Biology and treatment of childhood T\u2010lineage acute lymphoblastic leukemia","volume":"91","author":"Uckun F.M.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_68_1","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood.V90.10.4106","article-title":"p16 (INK4A) promotes differentiation and inhibits apoptosis of JKB acute lymphoblastic leukemia cells","volume":"90","author":"Urashima M.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_69_1","first-page":"125","article-title":"Childhood acute lymphoblastic leukemia in the Netherlands \u2013 randomized studies and nationwide treatment results from 1972 to 1995","volume":"5","author":"Van Der Does\u2010Van Den Berg A.","year":"1998","journal-title":"International Journal of Pediatric Hematology\/Oncology"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.5.1316.1316"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.3109\/08880019709030900"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02586.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02586.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2001.02586.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T09:29:11Z","timestamp":1697534951000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2001.02586.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["10.1046\/j.1365-2141.2001.02586.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02586.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3]]},"assertion":[{"value":"2001-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}